- Home
- ASH vs APGE Comparison
ASH vs APGE Comparison
Compare ASH & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASH
- APGE
- Stock Information
- Founded
- ASH 1924
- APGE 2022
- Country
- ASH United States
- APGE United States
- Employees
- ASH N/A
- APGE N/A
- Industry
- ASH Specialty Chemicals
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASH Consumer Discretionary
- APGE Health Care
- Exchange
- ASH Nasdaq
- APGE Nasdaq
- Market Cap
- ASH 2.3B
- APGE 2.6B
- IPO Year
- ASH N/A
- APGE 2023
- Fundamental
- Price
- ASH $53.39
- APGE $38.14
- Analyst Decision
- ASH Buy
- APGE Strong Buy
- Analyst Count
- ASH 5
- APGE 4
- Target Price
- ASH $70.50
- APGE $97.50
- AVG Volume (30 Days)
- ASH 553.6K
- APGE 1.4M
- Earning Date
- ASH 08-05-2025
- APGE 08-11-2025
- Dividend Yield
- ASH 3.05%
- APGE N/A
- EPS Growth
- ASH N/A
- APGE N/A
- EPS
- ASH N/A
- APGE N/A
- Revenue
- ASH $1,949,000,000.00
- APGE N/A
- Revenue This Year
- ASH N/A
- APGE N/A
- Revenue Next Year
- ASH $2.35
- APGE $743.14
- P/E Ratio
- ASH N/A
- APGE N/A
- Revenue Growth
- ASH N/A
- APGE N/A
- 52 Week Low
- ASH $45.21
- APGE $26.20
- 52 Week High
- ASH $98.44
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- ASH 56.60
- APGE 43.45
- Support Level
- ASH $52.34
- APGE $36.40
- Resistance Level
- ASH $55.44
- APGE $39.33
- Average True Range (ATR)
- ASH 1.56
- APGE 3.04
- MACD
- ASH 0.35
- APGE -0.83
- Stochastic Oscillator
- ASH 70.80
- APGE 20.25
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.